Operations

Everytable raises $25M

Provided by Everytable

June 27, 2023

Everytable, whose mission is to make nutritious food more accessible, has raised $25 million in the initial closing of its Series C-2 preferred stock financing. The funding will go toward the growth of Everytable's retail stores and food services business throughout Southern California, the Bay Area and New York City, according to a company press release that said the Los Angeles-based brand tripled its retail footprint in 2022 to nearly 50 locations and plans to add up to 25 stores by the end of 2023.

"We are inspired by the Dohmen Company's long history in the healthcare industry and their dedication to our shared mission to make nutritious food accessible to everyone, everywhere," Sam Polk, CEO and founder of Everytable, said in the release. "The continued commitment from our investors, despite a steep decline in venture funding overall, speaks volumes about their confidence in our ability to address one of the most pressing and persistent issues of our time."

The round was led by the Dohmen Company Foundation through the Dohmen Impact Investment Fund, focused on investing in companies capable of preventing and reversing diet-related diseases. Joining DCF are existing Everytable investors Creadev, Gullspång Re:foods and Kaiser Permanente Ventures.

"The Dohmen Impact Investment Fund is proud to make its inaugural investment in Everytable to realize the Fund's goal of making healthy eating ubiquitous," Rachel Roller, president and CEO of the Dohmen Company Foundation, said in the release. "We encourage other foundations, socially conscious businesses, and investors to join us in prioritizing investments in healthy food solutions, such as Everytable, to address the growing diet-related disease epidemic."

DCF and Everytable teams first connected through the 2022 White House Conference on Hunger Nutrition and Health, at which time both organizations committed to the President's goal of ending hunger and reducing diet-related diseases by 2030.